Renaissance Technologies (RenTech)'s NRXP Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 38,600 shares of NRx Pharmaceuticals, Inc. (NRXP) worth $157,874, representing 0.00% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in NRXP for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 38,600 shares. Largest reduction occurred in Q4 2025, reducing 128,175 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s NRx Pharmaceuticals (NRXP) Holding Value Over Time
Track share changes against reported price movement
Quarterly NRx Pharmaceuticals (NRXP) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +38,600 | New Buy | 38,600 | $4.09 |
| Q4 2025 | -128,175 | Sold Out | 0 | $0.00 |
| Q3 2025 | +128,175 | New Buy | 128,175 | $3.30 |
Renaissance Technologies (RenTech)'s NRx Pharmaceuticals Investment FAQs
Renaissance Technologies (RenTech) first purchased NRx Pharmaceuticals, Inc. (NRXP) in Q3 2025, acquiring 128,175 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held NRx Pharmaceuticals, Inc. (NRXP) for 3 quarters since Q3 2025.
Renaissance Technologies (RenTech)'s largest addition to NRx Pharmaceuticals, Inc. (NRXP) was in Q3 2025, adding 128,175 shares worth $422,978.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 38,600 shares of NRx Pharmaceuticals, Inc. (NRXP), valued at approximately $157,874.
As of the Q2 2026 filing, NRx Pharmaceuticals, Inc. (NRXP) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in NRx Pharmaceuticals, Inc. (NRXP) was 128,175 shares, as reported at the end of Q3 2025.